Article PDF
Avoid common mistakes on your manuscript.
Acknowledgment
The authors thank Wichor Bramer from the Erasmus MC Medical Library for developing the search strategy.
Study coordinators of the Erasmus MC Cancer Institute* for the International expert panel¥
*Study coordinators: Sjoerd M. Lagarde, MD1, Bianca Mostert, MD2, Joost J. M. E. Nuyttens, MD3, Manon C. W. Spaander, MD4, and Bas P. L. Wijnhoven, MD1. 1Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 2Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 3Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 4Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
¥International expert panel: Johanna W. van Sandick, MD5, Jolanda M. van Dieren, MD6, Francine E. M. Voncken, MD7, Jean-Pierre E. N. Pierie, MD8, Willem E. Fiets, MD9, Camiel Rosman, MD10, Peter D. Siersema, MD4,11, Heidi Rütten, MD12, Grard A. P. Nieuwenhuijzen, MD13, Geert-Jan Creemers, MD14, Erik J. Schoon, MD15, Maurice J. C. van der Sangen, MD16, Arjan Verschoor, MD17, Rutger Quisel, MD18, Meindert N. Sosef, MD19, Jeroen Buijsen, MD20, Hendrik H. Hartgrink, MD21, Marije Slingerland, MD22, Joos Heisterkamp, MD23, Laurens V. Beerepoot, MD24, Wouter L. Hazen, MD25, Tom Rozema, MD26, Karin Muller, MD27, Ewout A. Kouwenhoven, MD28, Simon Y. Law, MD29, Wendy W. Chan, MD30, Ian Y. Wong, MD29, Zhigang Li, MD31, Yin-Kai Chao, MD32, I-Chen Wu, MD33, Chiao-En Wu, MD34, Wing-Keen Yap, MD,35, Seong Yong Park, MD36, Hiroya Takeuchi, MD37, Eisuke Booka, MD37, Ken Kato, MD38, Ito Yoshinori, MD39, Steven H. Lin, MD40, Guillaume Piessen, MD41, Anthony Turpin, MD42, Alexandre Taillez, MD43, Carlo Castoro, MD44, Alessandro Bastoni, MD45, Roberta Maselli, MD46,47, Marta Scorsetti, MD48, Thomas N. Walsh, MD49, and Liam Grogan, MD50; ; 5Department of Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands; 6Department of Gastrointestinal Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands; 7Department of Radiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands; 8Department of Surgery, Medical Center Leeuwarden, Leeuwarden, the Netherlands; 9Department Medical Oncology, Medical Center Leeuwarden, Leeuwarden, the Netherlands; 10Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands; 11Department of Gastroenterology, Radboud University Medical Center, Nijmegen, the Netherlands; 12Department of Radiotherapy, Radboud University Medical Center, Nijmegen, the Netherlands; 13Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands; 14Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands; 15Department of Gastroenterology, Catharina Hospital, Eindhoven, the Netherlands; 16Department of Radiotherapy, Catharina Hospital, Eindhoven, the Netherlands; 17Department of Medical Oncology, Reinier de Graaf Group, Delft, the Netherlands; 18Department of Gastroenterology, Reinier de Graaf Group, Delft, the Netherlands; 19Department of Surgery, Zuyderland Medical Center, Heerlen, the Netherlands; 20Department of Radiotherapy, Zuyderland Medical Center, Heerlen, the Netherlands; 21Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands; 22Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands; 23Department of Surgery, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands; 24Department of Medical Oncology, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands; 25Department of Gastroenterology, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands; 26Department of Radiotherapy, Verbeeten Instituut, Tilburg, the Netherlands; 27Department of Radiotherapy, Radiotherapy Group, Apeldoorn, the Netherlands; 28Department of Surgery, Zorggroep Twente, Almelo, the Netherlands; 29Department of Surgery, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China; 30Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China; 31Department of Surgery, Shanghai Chest Hospital, Shanghai, China; 32Department of Surgery, Chang Gung Memorial Hospital-Linkou, Taipei, Taiwan; 33Department of Gastroenterology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; 34Department of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan; 35Department of Radiotherapy, Chang Gung Memorial Hospital-Linkou, Taipei, Taiwan; 36Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 37Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan; 38Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan; 39Department of Radiotherapy, National Cancer Center Hospital, Tokyo, Japan; 40Department of Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center; 41Univ. Lille, CNRS, Inserm, CHU Lille, Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France; 42Department of Radiation Oncology, Oscar Lambret Center, Lille, France; 43Department of Radiotherapy, Centre Oscar Lambret Center, Lille, France; 44Department of Surgery, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy; 45Department of Medical Oncology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy; 46Department of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy; 47Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy; 48Department of Radiotherapy, Humanitas Research Hospital - IRCCS, Rozzano, Milan, Italy; 49Department of Surgery, Connolly Hospital Blanchardstown, Dublin, Ireland; 50Department of Medical Oncology, Connolly Hospital Blanchardstown, Dublin, Ireland.
Funding
None declared.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Disclosures
Bianca Mostert: research funding from Sanofi, Pfizer and BMS; consulting/advisory for Lilly, Servier, BMS, Amgen and AstraZeneca. Bas Wijnhoven: research funding from BMS; consulting/advisory for BMS. Grard Nieuwenhuijzen: Consulting/advisory for Medtronic, Lilly. Guillaume Piessen: consulting/advisory for Nestle, BMS, MSD, Daiichi, Astellas. Ewout A. Kouwenhoven: consulting/advisory for Intuitive Surgical. Ken Kato: research funding from ONO, BMS, MSD; consulting/advisory for BMS, MSD, Beigene, Chugai, and BAYER. All remaining authors have declared no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
van der Zijden, C.J., Study Coordinators of the Erasmus MC Cancer Institute. & for the International Expert Panel. ASO Visual Abstract: International Expert Consensus on Semantics of Multimodal Esophageal Cancer Treatment—Delphi Study. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15544-x
Published:
DOI: https://doi.org/10.1245/s10434-024-15544-x